Basic Information
Basic information for FTX-226-33aa
Peptide Name FTX-226-33aa
Genome Position chrX:74005655-74005753[-]
Species Human
Peptide Sequence MYPRNHCPEQHHRAFPLYFLLVVLQFQRQHFRL
Peptide Length 33
Unique No (FTX-213-33aa,FTX-214-33aa,FTX-215-33aa,FTX-217-33aa,FTX-220-33aa)
Grand Average of Hydropathicity -0.4364
Relative Molecular Mass 4799.43
Experimental Evidences no
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000652319;FTX-226
Transcript Length 2137
Coding Ability 0.3234
DNA Sequence Corresponding to Peptide ATGTATCCAAGAAATCATTGCCCAGAACAACATCATAGAGCTTTTCCCCTATATTTTCTACTAGTAGTTTTACAGTTTCAAAGGCAACATTTCAGGCTT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :